Shoubhik Chakraborty | Health Professions | Best Researcher Award

Dr. Shoubhik Chakraborty | Health Professions | Best Researcher Award

Pediatric optometrist from Kalinga Institute of Medical Science, India

Shoubhik Chakraborty is a committed and dynamic professional in the field of Clinical Optometry, specializing in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment (CVI). He holds a Bachelor’s degree in Clinical Optometry and Vision Science from NSHM College of Management and Technology, affiliated with MAKAUT. His professional journey is marked by practical clinical experience and a keen interest in advanced vision therapy. Shoubhik has worked with prestigious institutions like Narayana Nethralaya, AIIMS Jodhpur, and currently serves as a Pediatric Optometrist at KIMS, Bhubaneswar. He has demonstrated his research capabilities through multiple scientific publications in peer-reviewed journals. Throughout his career, he has attended major optometry conferences, reflecting his commitment to professional development and learning. With a blend of strong clinical acumen, research enthusiasm, and a drive for innovation in optometry, Shoubhik is poised to contribute meaningfully to the advancement of pediatric vision care. His passion for restoring and enhancing vision, especially among children and individuals with neurological visual impairments, is evident in both his clinical work and academic pursuits. He brings a mix of leadership, creativity, and critical thinking to every assignment, showing potential for further academic and clinical excellence.

Professional Profile

Education

Shoubhik Chakraborty’s educational background showcases a strong foundation in optometry and vision science. He completed his secondary education at Sagardighi Thermal Power School (2014–2015) under the West Bengal Board of Secondary Education (WBBSE) and his higher secondary studies at Karaiya High School (2015–2017) affiliated with the West Bengal Council of Higher Secondary Education (WBCHSE). Building on his early academic success, he pursued a Bachelor’s degree in Clinical Optometry and Vision Science (2017–2021) at NSHM College of Management and Technology, under MAKAUT. During his academic years, he completed vocational training at Susrut Eye Foundation and Research Centre, Kolkata, and undertook a comprehensive internship at MGM Eye Institute, Raipur, Chhattisgarh. Recognizing the importance of specialized training, Shoubhik further pursued a Fellowship in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment from Narayana Nethralaya, Bangalore, which he completed between August 2021 and January 2023. His academic background has been complemented by seminars, workshops, and continuous learning in vision therapy and neuro-optometry, equipping him with the latest techniques and research-based practices in his field.

Professional Experience

Shoubhik Chakraborty’s professional journey reflects a strong commitment to clinical excellence and research-oriented optometry practice. After completing his Bachelor’s degree and internship, he pursued a Fellowship at Narayana Nethralaya, Bangalore, specializing in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment. Post-fellowship, Shoubhik worked as a Cerebral Visual Impairment Specialist at the prestigious All India Institute of Medical Sciences (AIIMS), Jodhpur, from February 2023 to August 2023. His role at AIIMS involved specialized diagnosis, management, and vision therapy for children with complex neurological visual disorders. Currently, he is employed as a Pediatric Optometrist at KIMS, Bhubaneswar, where he continues to apply and expand his clinical and research expertise. His clinical practice integrates evidence-based methods for treating amblyopia, strabismus, and CVI, and he remains actively involved in patient-centered therapy programs. Shoubhik’s career also includes participation in national conferences, presenting his findings and staying updated with the latest advancements in pediatric and behavioral optometry. His hands-on experience across multiple renowned institutions, combined with research activities and a focus on clinical innovation, positions him as a promising healthcare professional with aspirations for greater leadership in optometry and vision research.

Research Interests

Shoubhik Chakraborty’s research interests center around Pediatric Optometry, Binocular Vision Anomalies, Cerebral Visual Impairment (CVI), Amblyopia Management, and Behavioral Optometry. He is particularly passionate about advancing the understanding of vision therapy and its long-term effects on children with neurological visual impairments. His work focuses on the development and validation of customized vision therapy programs aimed at improving binocular function, stereopsis, and visual acuity in children and young adults. He is also interested in studying the outcomes of early intervention therapies for amblyopia, anisometropia, and CVI, and their impact on patients’ overall quality of life. Shoubhik actively explores neuroplasticity and rehabilitation strategies to help children with brain injuries or developmental delays regain visual function. His goal is to bridge clinical practice and research by developing standardized protocols for vision therapy and contributing to evidence-based pediatric optometry. Furthermore, he is keen on future research collaborations that integrate neuro-optometric rehabilitation with technological innovations such as digital therapies and telehealth models to expand access to specialized vision care services.

Research Skills

Shoubhik Chakraborty possesses a wide range of research and clinical skills critical to his specialization. His research competencies include designing and executing clinical studies, performing statistical analysis of therapy outcomes, critical literature review, and drafting manuscripts for peer-reviewed publication. In clinical practice, he is skilled in the assessment and management of binocular vision disorders, orthoptic evaluations, pediatric visual development assessments, and neuro-optometric rehabilitation for CVI patients. Shoubhik also demonstrates proficiency in customized vision therapy techniques, including anti-suppression therapy, vergence therapy, and accommodative facility enhancement. His training has equipped him with the ability to critically analyze therapy outcomes and continuously refine intervention strategies. He has excellent skills in decision-making, critical thinking, creativity, teamwork, and leadership, which are crucial for multidisciplinary collaboration in clinical research settings. He also holds a diploma in computer applications, enabling him to efficiently manage patient data, conduct research documentation, and prepare presentations. Shoubhik’s ability to merge research rigor with clinical sensitivity makes him well-suited for future roles involving innovation in pediatric optometry and vision science.

Awards and Honors

Shoubhik Chakraborty’s academic and professional journey has been marked by notable achievements and recognitions. His most significant honors come through his contributions to scientific publications in reputed optometry journals. His case study on restoring binocular vision in a 23-year-old myopic anisometropic amblyopia patient was published in Optometry and Visual Performance (October 2023). His retrospective study on the outcomes of vision therapy among children with Cerebral Visual Impairment was also accepted and published in Optometry and Visual Performance (March 2024). Furthermore, his research on the impact of active vision therapy on anisometropic amblyopia cases was published in EC Ophthalmology (September 2024). Beyond publishing, his participation in national-level conferences like the Asia Pacific Optometry Summit, Bengal Optometry Conference, Kolkata Optometry Conference, and Karnataka Optometry Conference demonstrates his active engagement in the professional community. His Fellowship in Pediatric Optometry and Cerebral Visual Impairment from Narayana Nethralaya is another key milestone that highlights his commitment to clinical and academic excellence. These achievements position him as a promising young optometrist with potential for greater recognition and leadership in vision science.

Conclusion

In conclusion, Shoubhik Chakraborty is a highly motivated and emerging professional in the field of optometry, showing commendable progress in both clinical practice and research. His educational background, fellowship training, and hands-on experience with specialized populations such as children with Cerebral Visual Impairment underline his dedication to advancing pediatric vision care. His publications in peer-reviewed journals demonstrate his ability to contribute meaningful research to the field. With strong clinical skills, research acumen, leadership qualities, and a commitment to continuous learning, Shoubhik is well-positioned to make significant contributions to pediatric optometry and vision therapy research. To further strengthen his professional trajectory, he could consider expanding his research portfolio through multicenter studies and pursuing advanced degrees such as a Master’s or Ph.D. Overall, Shoubhik embodies the qualities of a future leader in clinical optometry and research, and he is well-deserving of encouragement and support for higher academic and professional achievements.

Publications Top Notes

  • Recovering Vision and Binocularity in a Presbyopic Patient with Amblyopia
    Authors: SD Shoubhik Chakraborty, Hajira R
    Journal: VDR, Vol. 11(1), p. 48
    Year: 2025

  • Prevalence of Accommodative Insufficiency in Children With Normal Accommodative-Convergence/Accommodation Ratio and Its Association With Refractive Error: A Cross-Sectional Study
    Authors: S Chakraborty, S Parida, SK Mohanty, M Das, S Dash, S Mohanty
    Journal: Cureus, Vol. 17(2)
    Year: 2025

  • The Role of Vision Therapy in the Management of Recurrent Hordeolum
    Authors: S Chakraborty, PP Sahu, SK Mohanty, R Hajira
    Year: 2025

  • Treatment of Anisometropic Amblyopia Using a Combination Approach
    Authors: HR Shoubhik Chakraborty, Shrutakirty Parida
    Journal: VDR, Vol. 10(4), p. 187
    Year: 2024

  • The Impact of Active Vision Therapy on Vision and Binocularity for Anisometropic Amblyopia Cases
    Authors: SR Shoubhik Chakraborty, Shrutakirty Parida, Sahanaz Hossain
    Journal: EC Ophthalmology
    Year: 2024

  • Outcomes Of Vision Therapy Among Children with Cerebral Visual Impairment: A Retrospective Study
    Authors: S Chakraborty, P Sarbajna, A Vinekar, B Shetty
    Journal: Optometry & Visual Performance, Vol. 12(1)
    Year: 2024

  • Case Report: Enhancing Binocular Vision of an Adult with Anisometropic Amblyopia
    Authors: S Chakraborty, P Sarbajna, A Vinekar, B Shetty
    Journal: Optometry & Visual Performance, Vol. 11(3)
    Year: 2023

  • Treatment of Anisometropic Amblyopia Using a Combination Approach (Duplicate Title)
    Authors: S Chakraborty, B Optom, S Parida, R Hajira

  • Let’s Delve Into the Least Explored Visual Pathway
    Author: S Chakraborty

Minji Jung | Health Professions | Best Researcher Award

Dr. Minji Jung | Health Professions | Best Researcher Award

Postdoctoral Scholar at Stanford University Medical Center, United States

Minji Jung is a prominent researcher with expertise in cancer epidemiology, pharmacoepidemiology, and risk factors for chronic diseases such as kidney cancer and cardiovascular conditions. She currently serves as a Postdoctoral Scholar at the Urologic Cancer Epidemiology Lab at Stanford University School of Medicine. Minji has an extensive academic background, earning a PhD in Clinical Pharmacoepidemiology and holding a PharmD degree from Ajou University, South Korea. Her research has spanned multiple high-impact areas, including kidney cancer, cardiovascular diseases, and dementia, with a focus on real-world data analysis. Minji has secured significant research funding, led interdisciplinary projects, and earned numerous awards, underscoring her substantial contributions to health sciences. Her work integrates diverse data sets, cutting-edge statistical methods, and collaborative partnerships, making her a leading figure in her field.

Professional Profile

Education:

Minji Jung holds a PharmD from Ajou University in South Korea, completed in 2016, where she also earned her PhD in Clinical Pharmacoepidemiology in 2021. During her doctoral studies, Minji focused on evaluating the pleiotropic effects of statin therapy, specifically investigating its potential role in preventing hemorrhagic stroke and dementia using Korean nationwide health insurance data. She has further honed her expertise as a Research Fellow at the University of California, San Francisco, in 2021-2022, specializing in pharmacoepidemiology related to cardiovascular disease. Minji’s education has been marked by a strong foundation in clinical pharmacy, epidemiology, and data analytics, laying the groundwork for her current focus on urologic cancer and cardio-oncology research.

Professional Experience:

Minji Jung’s professional journey includes roles in academia and research, where she has made significant strides in clinical pharmacy and epidemiology. She is currently a Postdoctoral Scholar at Stanford University’s Urologic Cancer Epidemiology Lab, where she focuses on cancer epidemiology, pharmacoepidemiology, and kidney cancer research. Previously, she served as a Research Fellow at the University of California, San Francisco, contributing to studies on cardiovascular disease and medication adherence. Minji’s early research experience includes working at Ajou University, South Korea, where she contributed to pharmacoepidemiological projects examining the effects of statin use and its association with stroke and dementia. Her expertise spans across both clinical and epidemiological settings, enabling her to integrate real-world data into her research and offering valuable insights into chronic disease prevention and management.

Research Interests:

Minji Jung’s research interests are centered on cancer epidemiology, pharmacoepidemiology, and the intersection of chronic diseases such as kidney cancer, cardiovascular conditions, and dementia. Her work focuses on understanding the epidemiology and risk factors associated with kidney cancer, analyzing large health data sets to explore connections between metabolic syndrome and cancer incidence. Additionally, Minji is deeply invested in survivorship and psycho-oncology, exploring the mental and physical health outcomes of patients diagnosed with cancer. Her research also delves into cardio-oncology, investigating the cardiovascular risks of cancer patients, especially those undergoing treatment. By using advanced statistical methods and diverse global data sets, Minji aims to improve the prevention, diagnosis, and treatment of chronic diseases, with a focus on kidney cancer and its broader implications for public health.

Research Skills:

Minji Jung possesses advanced research skills, particularly in epidemiological methods, pharmacoepidemiology, and statistical analysis. She is adept at handling large, diverse data sets, such as SEER, UK Biobank, and MarketScan® data, and has expertise in applying a variety of statistical techniques, including logistic regression, survival analysis, propensity score matching, and Cox regression models. Minji is skilled in utilizing real-world data to study the epidemiology of chronic diseases and their interactions with medications. Her proficiency in data analysis is complemented by her ability to integrate findings from multiple disciplines, allowing her to draw meaningful conclusions that influence clinical and public health policies. Minji is also experienced in project management, having led her own research initiatives, and is well-versed in the application of innovative research methods to investigate complex health issues.

Awards and Honors:

Minji Jung has received numerous awards in recognition of her exceptional research contributions. Notably, she was honored with the Poster Award from the Western Section of the American Urological Association in 2024 and was selected as a Notable Scientist by the Korean Biological Research Information Center in 2023. She also won the Oral Presentation Award at the 24th Annual Spring Research Seminar at the University of California, San Francisco, in 2022. Minji’s achievements are further highlighted by an Oral Presentation Award from the Pharmaceutical Society of Korea in 2019, as well as a Certificate of Commendation from the Suwon Pharmaceutical Association in 2018. These accolades reflect the high regard in which she is held by the scientific community, emphasizing her impactful research in the fields of epidemiology and pharmacoepidemiology.

Conclusion

Minji Jung has demonstrated exceptional research capabilities in areas that have profound implications for public health, particularly in cancer epidemiology and pharmacoepidemiology. Her leadership in securing research grants and contributing to significant health-related findings sets her apart as a candidate for the Best Researcher Award. While there are areas that could be further strengthened, particularly in terms of broadening her influence in the public sphere and maximizing publication impact, her accomplishments thus far make her a highly deserving nominee for the award.

Publication Top Notes

  • Effects of statin therapy on the risk of intracerebral hemorrhage in Korean patients with hyperlipidemia
    Authors: M Jung, S Lee
    Year: 2019
    Citations: 22
  • Impact of statin use on dementia incidence in elderly men and women with ischemic heart disease
    Authors: MY Kim, M Jung, Y Noh, S Shin, CH Hong, S Lee, YS Jung
    Year: 2020
    Citations: 18
  • Efficacy of aspirin in the primary prevention of cardiovascular diseases and cancer in the elderly: a population-based cohort study in Korea
    Authors: M Jung, S Lee
    Year: 2020
    Citations: 10
  • Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide
    Authors: G Jin, HV Ngo, J Wang, JH Cui, QR Cao, C Park, M Jung, BJ Lee
    Year: 2022
    Citations: 8
  • Comprehensive trends and patterns of antihypertensive prescriptions using a nationwide claims database in Korea
    Authors: M Jung, E Choo, S Lee
    Year: 2020
    Citations: 7
  • Comparing the sensitivities of measures of adherence to antihypertensive drugs using Korean National Health Insurance Claims Data
    Authors: E Choo, M Jung, J Shin, S Lee
    Year: 2021
    Citations: 5
  • Clinical pharmacokinetic study of tacrolimus in continuous intravenous administration for lung transplantation
    Authors: YM Sohn, RE Ko, HJ Park, E Choo, M Jung, S Lee, K Jeon
    Year: 2023
    Citations: 1
  • A comparison of methods for the measurement of adherence to antihypertensive multidrug therapy and the clinical consequences: a retrospective cohort study using the Korean National Health Insurance Claims Data
    Authors: M Jung, E Choo, S Lee
    Year: 2023
    Citations: 1
  • Effects of Postprandial Factors and Second Meal Intake Time on Bioequivalence Investigation of Tadalafil-Loaded Orodispersible Films in Human Volunteers
    Authors: SJ Park, MC Gil, BS Lee, M Jung, BJ Lee
    Year: 2024
    Citations: Not listed yet
  • Air pollution mixture associated with oxidative stress exacerbation and symptoms deterioration in allergic rhinitis patients: Evidence from a panel study
    Authors: J Li, H Wu, W Xing, X Li, Z Han, R Ji, Z Deng, M Jung, S Sun, BI Chung, …
    Year: 2024